12 p.m. ET
Biologics and Biosimilars: Understanding Their Role In Your Care is a webinar and panel discussion introducing patients to biologic treatments and what makes them different from traditional drug treatments.
We will be joined by an expert in biosimilars-development, a physician who prescribes biologics for her patients, as well as two patients with experience with biologics.
Come away with a better understanding of what biologics and biosimilars can do for you as a treatment.
Huma Sheikh, MD
Dr Sheikh graduated from UMDNJ- Rutgers Medical School and then completed a Neurology residency at Montefiore Medical Center in Bronx NY. She then completed a Vascular Fellowship followed by another fellowship in “Headache and Facial Pain,” at Brigham & Women’s Hospital- Harvard Medical School. She now has over 6 years of clinical experience treating complex headaches and takes a holistic approach. She is educated in the latest medications for headaches and specifically migraines as well as the latest complementary treatments. She is also involved in research and started the “Migraine and Vascular Committee,” at the American Headache Society (AHS). She is also now co-chair of the Women and Migraine Section at AHS.
As Executive Director, Global Value Access and Policy for Amgen’s Biosimilars Business Unit, Chad Pettit develops global market access launch strategy for Amgen’s portfolio of 10 biosimilar medicines. He serves as a liaison with the biopharmaceutical industry on policy matters in biosimilars, a rapidly growing segment of the Amgen business. With his global perspective, Chad is recognized as an expert on biosimilar commercialization, market access for biosimilars, and the policy measures required to facilitate cost savings for patients and the health care system over the long-run.
As the Co-founder and Executive Director of Patients Rising, Terry helps patients find their voice and become outspoken advocates for their health care. She manages all of the day to day operations for the organization and is the visionary behind all of Patients Rising’s programs, including: Patients Rising University (education), Patients Rising Concierge (support), Institute for Patient Access & Affordability Project (research), and the policy and advocacy work of Patients Rising Now. She has a track record of building coalitions with patients, caregivers, and medical professionals. A regular opinion writer on health policy and how it affects patients, she has been published in the Boston Globe, The Hill, Morning Consult, Crains NY, Real Clear Health, the American Thinker, and more. Terry’s career in patient advocacy was inspired by her mentor Selma Schimmel, considered by many as the “original” young adult survivor advocate.
Kristina Wolfe is a Director in the IRB & Ethics division of WCG. She does not like being defined by her credentials, disease, profession, age, race, gender or hobbies, but loves helping others. She has lived with Type I Diabetes for over 25 years, has used all the gadgets, hacked her own treatment, and has studied mental health co-morbidities of living with conditions. The result of her studies, and desire to find a solution, led her to co-found Our Odyssey, which provides year-round social and emotional support for young adults impacted by both rare and chronic conditions. Kristina loves adventuring & pushing herself to be better, especially in the gym. She is native to the small beach town, Wilmington, NC, where (most) everyone smiles, waves and knows your name.
Callum is a twenty-something Filipinx artist residing in Chicago. They spend most of their time starting (but rarely finishing) paintings and working on community projects. They’re focused on intersectional causes centered around patient advocacy, LGBT rights, and racial equity.
Their perspective is informed by their experiences as a patient, person of color, young person, and queer individual-identities, which pushed them into the world of activism. Their goal is to help share the narrative of the younger generation, and to start conversations on accessibility. Ultimately, they’d like to provide more resources to marginalized communities.
Get notified about new stories and resources to empower patients and caregivers.